Point72 Asset Management
ETON icon

Point72 Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Point72 Asset Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,925
Closed -$219K – 3982
2025
Q4 		$219K Buy
+12,925
New +$227K ﹤0.01% 3604
2025
Q2 		– Sell
-1,500
Closed -$19.5K – 2317
2025
Q1 		$19.5K Buy
+1,500
New +$22.7K ﹤0.01% 1973

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Point72 Asset Management's ETON Position: Q1 2026 in Review

Point72 Asset Management sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 12,925 shares — an estimated $219K sold.

Point72 Asset Management first reported a position in ETON in Q1 2025 and held it in 2 quarters. The position peaked at $219K in Q4 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Point72 Asset Management reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 12,925 Eton Pharmaceutcials shares in Q1 2026, an estimated $219K.
  • Point72 Asset Management first reported a position in Eton Pharmaceutcials in Q1 2025 and held it in 2 quarters.
  • Point72 Asset Management's Eton Pharmaceutcials position peaked at $219K in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.